Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2-to 3-Year Period in Premenopausal Women
  2. Eliassen, A. H.; Ziegler, R. G.; Rosner, B.; Veenstra, T. D.; Roman, J. M.; Xu, X.; Hankinson, S. E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(11): 2860-2868.
  1. 2.   Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis)
  2. Scott, L. M.; Xu, X.; Veenstra, T. D.; Tooze, J. A.; Wood, C. E.; Register, T. C.; Kock, N. D.; Cline, J. M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(10): 2594-2602.
  1. 3.   Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide
  2. Varricchio, L.; Migliaccio, A.; Castoria, G.; Yamaguchi, H.; de Falco, A.; Di Domenico, M.; Giovannelli, P.; Farrar, W.; Appella, E.; Auricchio, F.
  3. Molecular Cancer Research. 2007, Nov; 5(11): 1213-1221.
  1. 4.   New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
  2. De Martino, G.; Edler, M. C.; La Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 947-954.
  1. 5.   Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
  2. Feng, Y.; Zhu, Z. Y.; Xiao, X. D.; Choudhry, V.; Barrett, J. C.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2006, JAN; 5(1): 114-120.
  1. 6.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 7.   Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
  2. Sun, R. H.; Gao, P.; Chen, L.; Ma, D. L.; Wang, J. M.; Oppenheim, J. J.; Zhang, N.
  3. Cancer Research. 2005, FEB 15; 65(4): 1433-1441.
  1. 8.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 9.   Arylthioindoles, potent inhibitors of tubulin polymerization
  2. De Martino, G.; La Regina, G.; Coluccia, A.; Edler, M. C.; Barbera, M. C.; Brancale, A.; Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2004, DEC 2; 47(25): 6120-6123.
  1. 10.   Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization
  2. Edsall, A. B.; Mohanakrishnan, A. K.; Yang, D. L.; Fanwick, P. E.; Hamel, E.; Hanson, A. D.; Agoston, G. E.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5126-5139.
  1. 11.   Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Fan, Y. X.; Xiao, W. H.; Howard, O. M. Z.; Appella, E.; Maynard, A. T.; Farrar, W. L.
  3. Nature Medicine. 2004 10(1): 40-47.
  1. 12.   Cytotoxic alkaloids from the marine sponge Thorectandra sp
  2. Charan, R. D.; McKee, T. C.; Boyd, M. R.
  3. Natural Product Research. 2004 18(3): 225-229.
  1. 13.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 14.   DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1 alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
  2. Kaluzova, M.; Kaluz, S.; Lerman, M. I.; Stanbridge, E. J.
  3. Molecular and Cellular Biology. 2004 24(13): 5757-5766.
  1. 15.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
  1. 16.   DNA damage and cell cycle arrest induced by 2-(4-amino-3- methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells
  2. Trapani, V.; Patel, V.; Leong, C. O.; Ciolino, H. P.; Yeh, G. C.; Hose, C.; Trepel, J. B.; Stevens, M. F. G.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. British Journal of Cancer. 2003 88(4): 599-605.
  1. 17.   The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen- activated protein kinase activity
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Xiao, W. H.; Farrar, W. L.
  3. Cancer Research. 2003 63(9): 2046-2051.
  1. 18.   Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen
  2. Landon, L. A.; Peletskaya, E. N.; Glinsky, V. V.; Karasseva, N.; Quinn, T. P.; Deutscher, S. L.
  3. Journal of Protein Chemistry. 2003 22(2): 193-204.
  1. 19.   Hydrocarbon carcinogens induce p53 activity in normal mouse tissue (vol 173, pg 111, 2001)
  2. Stuart, D.; Khan, Q. A.; Brown, R.; Dipple, A.
  3. Cancer Letters. 2003 195(1): 121-121.
  1. 20.   Anti-tumor2-(4-Aminophenyl)-5-fluoro-benzothiazole (5F203, NSC 703786) induces single-strand breaks and DNA-protein cross- links in sensitive MCF-7 breast cancer cells
  2. Brantley, E.; Stinson, S.; Kohlhagen, G.; Antony, S.; Sausville, E.; Pommier, Y.
  3. Clinical Cancer Research. 2003 9(16): 6075S-6075S.
  1. 21.   Resistance of MCF-7 cells to dimethylbenz(a)anthracene-induced apoptosis is due to reduced CYP1A1 expression
  2. Ciolino, H. P.; Dankwah, M.; Yeh, G. C.
  3. International Journal of Oncology. 2002 21(2): 385-391.
  1. 22.   Modulation of cyclophilin gene expression by N-4- (hydroxyphenyl)retinamide: Association with reactive oxygen species generation and apoptosis
  2. Hursting, S. D.; Shen, J. C.; Sun, X. Y.; Wang, T. T. Y.; Phang, J. M.; Perkins, S. N.
  3. Molecular Carcinogenesis. 2002 33(1): 16-24.
  1. 23.   Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells
  2. Khan, Q. A.; Dipple, A.; Anderson, L. M.
  3. Molecular Carcinogenesis. 2002 33(1): 1-8.
  1. 24.   Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines
  2. Khan, Q. A.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2001 173(2): 105-113.
  1. 25.   Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; Is chemoprevention against multidrug resistance possible?
  2. Ratnasinghe, D.; Daschner, P. J.; Anver, M. R.; Kasprzak, B. H.; Taylor, P. R.; Yeh, G. C.; Tangrea, J. A.
  3. Anticancer Research. 2001 21(3C): 2141-2147.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel